AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced the safety and efficacy results from the Registry of AngioVac* System Procedures In Detail (RAPID) database. Results were shared by principal investigator John Moriarty, MD, FSIR, FSVM (Associate Professor of Radiology and Medicine, Cardiology—UCLA Interventional Radiology, David Geffen S